title: The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease.
abstract: This pilot study investigated effectiveness and tolerability of risperidone for the treatment of psychosis and agitation in 9 inpatients with Parkinson's disease and dementia. Investigators found risperidone to be effective and safe, without worsening extrapyramidal symptoms or further impairing cognition.
authors.affiliation: Veterans Affairs Medical Center, Houston, Texas 77030, USA. workman.richardvhvjr@houston.va.gov
authors.forename: R H
authors.initials: RH
authors.lastname: Workman
authors.forename: C A
authors.initials: CA
authors.lastname: Orengo
authors.forename: A A
authors.initials: AA
authors.lastname: Bakey
authors.forename: V A
authors.initials: VA
authors.lastname: Molinari
authors.forename: M E
authors.initials: ME
authors.lastname: Kunik
mesh_terms: D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003704:Dementia / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000150:complications* / Q000523:psychology; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D011595:Psychomotor Agitation / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D018967:Risperidone